Literature DB >> 23168286

Relation of vitamin D and parathyroid hormone to cardiac biomarkers and to left ventricular mass (from the Cardiovascular Health Study).

Adriana J van Ballegooijen1, Marjolein Visser, Bryan Kestenbaum, David S Siscovick, Ian H de Boer, John S Gottdiener, Christopher R deFilippi, Ingeborg A Brouwer.   

Abstract

Vitamin D and parathyroid hormone (PTH) may affect cardiovascular health in patients with kidney disease and in the general population. The aim of this study was to investigate associations of serum 25-hydroxyvitamin D (25(OH)D) and PTH concentrations with a comprehensive set of biochemical, electrocardiographic, and echocardiographic measurements of cardiac structure and function in the Cardiovascular Health Study. A total of 2,312 subjects who were free of cardiovascular disease at baseline were studied. Serum 25(OH)D and intact PTH concentrations were measured using mass spectrometry and a 2-site immunoassay. Outcomes were N-terminal pro-B-type natriuretic peptide, cardiac troponin T, electrocardiographic measures of conduction, and echocardiographic measures of left ventricular mass and diastolic dysfunction. At baseline, subjects had a mean age of 73.9 ± 4.9 years, 69.7% were women, and 21% had chronic kidney disease (glomerular filtration rate <60 ml/min). Mean 25(OH)D was 25.2 ± 10.2 ng/ml, and median PTH was 51 pg/ml (range 39 to 65). After adjustment, 25(OH)D was not associated with any of the biochemical, conduction, or echocardiographic outcomes. Serum PTH levels ≥65 pg/ml were associated with greater N-terminal pro-B-type natriuretic peptide, cardiac troponin T, and left ventricular mass in patients with chronic kidney disease. The regression coefficients were: 120 pg/ml (95% confidence interval 36.1 to 204), 5.2 pg/ml (95% confidence interval 3.0 to 7.4), and 17 g (95% confidence interval 6.2 to 27.8) (p <0.001). In subjects with normal kidney function, PTH was not associated with the outcomes. In conclusion, in older adults with chronic kidney disease, PTH excess is associated with higher N-terminal pro-B-type natriuretic peptide, cardiac troponin T, and left ventricular mass. These findings suggest a role for PTH in cardiovascular health and the prevention of cardiac diseases.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23168286      PMCID: PMC3546140          DOI: 10.1016/j.amjcard.2012.10.021

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  30 in total

1.  Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

Authors:  Christopher R deFilippi; James A de Lemos; Robert H Christenson; John S Gottdiener; Willem J Kop; Min Zhan; Stephen L Seliger
Journal:  JAMA       Date:  2010-11-15       Impact factor: 56.272

2.  Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidism.

Authors:  Carlos A Feldstein; Maia Akopian; Daniel Pietrobelli; Antonio Olivieri; Delia Garrido
Journal:  Clin Exp Hypertens       Date:  2010-05       Impact factor: 1.749

3.  Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease.

Authors:  Eric N Taylor; Eric B Rimm; Meir J Stampfer; Gary C Curhan
Journal:  Am Heart J       Date:  2011-05       Impact factor: 4.749

4.  Vitamin D deficiency and myocardial structure and function in older men and women: the Hoorn study.

Authors:  S Pilz; R M A Henry; M B Snijder; R M van Dam; G Nijpels; C D A Stehouwer; O Kamp; A Tomaschitz; T R Pieber; J M Dekker
Journal:  J Endocrinol Invest       Date:  2010-03-05       Impact factor: 4.256

5.  Cardiac structure and diastolic function in mild primary hyperparathyroidism.

Authors:  M D Walker; J B Fleischer; M R Di Tullio; S Homma; T Rundek; E M Stein; C Zhang; T Taggart; D J McMahon; S J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2010-03-12       Impact factor: 5.958

6.  Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.

Authors:  Andreas Tomaschitz; Stefan Pilz; Eberhard Ritz; Tanja Grammer; Christiane Drechsler; Bernhard O Boehm; Winfried März
Journal:  Clin Chim Acta       Date:  2010-06-01       Impact factor: 3.786

7.  Plasma parathyroid hormone and risk of congestive heart failure in the community.

Authors:  Emil Hagström; Erik Ingelsson; Johan Sundström; Per Hellman; Tobias E Larsson; Lars Berglund; Håkan Melhus; Claes Held; Karl Michaëlsson; Lars Lind; Johan Arnlöv
Journal:  Eur J Heart Fail       Date:  2010-08-26       Impact factor: 15.534

8.  25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification.

Authors:  Ian H de Boer; Bryan Kestenbaum; Abigail B Shoben; Erin D Michos; Mark J Sarnak; David S Siscovick
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

Review 9.  Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Authors:  R Eastell; A Arnold; M L Brandi; E M Brown; P D'Amour; D A Hanley; D Sudhaker Rao; M R Rubin; D Goltzman; S J Silverberg; S J Marx; M Peacock; L Mosekilde; R Bouillon; E M Lewiecki
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

10.  Associations of vitamin D, parathyroid hormone and calcium with cardiovascular risk factors in US adolescents.

Authors:  Dylan M Williams; Abigail Fraser; Debbie A Lawlor
Journal:  Heart       Date:  2010-12-30       Impact factor: 5.994

View more
  26 in total

Review 1.  Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia.

Authors:  David M Charytan; Steven Fishbane; Jolanta Malyszko; Peter A McCullough; David Goldsmith
Journal:  Am J Kidney Dis       Date:  2015-02-26       Impact factor: 8.860

2.  Parathormone Levels Are Independently Associated with the Presence of Left Ventricular Hypertrophy in Patients with Coronary Artery Disease.

Authors:  Á Aceña; A M Pello; R Carda; Ó Lorenzo; M L Gonzalez-Casaus; L M Blanco-Colio; J L Martín-Ventura; J Palfy; M Orejas; R Rábago; E Gonzalez-Parra; I Mahíllo-Fernández; J Farré; J Egido; J Tuñón
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

Review 3.  The renin-angiotensin-aldosterone system and calcium-regulatory hormones.

Authors:  A Vaidya; J M Brown; J S Williams
Journal:  J Hum Hypertens       Date:  2015-01-29       Impact factor: 3.012

Review 4.  Vitamin D and cardiovascular disease prevention.

Authors:  Stefan Pilz; Nicolas Verheyen; Martin R Grübler; Andreas Tomaschitz; Winfried März
Journal:  Nat Rev Cardiol       Date:  2016-05-06       Impact factor: 32.419

Review 5.  Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease.

Authors:  David Charytan
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-11       Impact factor: 2.894

6.  Hypertension, Antihypertensive Medications, and Risk of Incident Primary Hyperparathyroidism.

Authors:  Anand Vaidya; Gary C Curhan; Julie M Paik; Henry Kronenberg; Eric N Taylor
Journal:  J Clin Endocrinol Metab       Date:  2015-04-17       Impact factor: 5.958

7.  Vitamin D Status and Exercise Capacity in Older Patients with Heart Failure with Preserved Ejection Fraction.

Authors:  Ambarish Pandey; Dalane W Kitzman; Denise K Houston; Haiying Chen; M Kyla Shea
Journal:  Am J Med       Date:  2018-08-01       Impact factor: 4.965

8.  Serum vitamin D and parathyroid hormone in relation to cardiac structure and function: the ICELAND-MI substudy of AGES-Reykjavik.

Authors:  A J van Ballegooijen; M Visser; M F Cotch; A E Arai; M Garcia; T B Harris; L J Launer; G Eiríksdóttir; V Gudnason; I A Brouwer
Journal:  J Clin Endocrinol Metab       Date:  2013-04-12       Impact factor: 5.958

9.  Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.

Authors:  Jenifer M Brown; Jonathan S Williams; James M Luther; Rajesh Garg; Amanda E Garza; Luminita H Pojoga; Daniel T Ruan; Gordon H Williams; Gail K Adler; Anand Vaidya
Journal:  Hypertension       Date:  2013-11-04       Impact factor: 10.190

10.  Independent and Synergistic Associations of Biomarkers of Vitamin D Status With Risk of Coronary Heart Disease.

Authors:  Lu Qi; Wenjie Ma; Yoriko Heianza; Yan Zheng; Tiange Wang; Dianjianyi Sun; Eric B Rimm; Frank B Hu; Edward Giovannucci; Christine M Albert; Kathryn M Rexrode; JoAnn E Manson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-09-07       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.